<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02864862</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-DB-16-0286</org_study_id>
    <nct_id>NCT02864862</nct_id>
  </id_info>
  <brief_title>Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation</brief_title>
  <official_title>Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the esthetic outcomes following immediate implant&#xD;
      combined with the autogenous tissue graft or acellular dermal matrix compared to immediate&#xD;
      implant alone.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Anticipated">December 12, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 12, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in ridge dimensional alteration</measure>
    <time_frame>baseline, 6 months after surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in gingival level</measure>
    <time_frame>baseline, 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in gingival thickness</measure>
    <time_frame>baseline, 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in width of keratinized gingiva</measure>
    <time_frame>baseline, 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in alveolar bone level</measure>
    <time_frame>baseline, 6 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in bone dimension</measure>
    <time_frame>baseline, 6 months after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Dental Implant</condition>
  <condition>Immediate Dental Implant</condition>
  <condition>Soft Tissue Augmentation</condition>
  <arm_group>
    <arm_group_label>Immediate implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Immediate implant alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immediate implant combined with SCTG</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subepithelial connective tissue graft (SCTG)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immediate implant combined with ADM</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acellular dermal matrix (ADM)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Immediate implant</intervention_name>
    <arm_group_label>Immediate implant</arm_group_label>
    <arm_group_label>Immediate implant combined with ADM</arm_group_label>
    <arm_group_label>Immediate implant combined with SCTG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>SCTG</intervention_name>
    <arm_group_label>Immediate implant combined with SCTG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>ADM</intervention_name>
    <arm_group_label>Immediate implant combined with ADM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients who are in need of a tooth extraction at the maxillary premolar, canine and&#xD;
             incisor region, and subsequent single implant placement.&#xD;
&#xD;
          -  The reasons for extraction will include poor endodontic prognosis and/or unrestorable&#xD;
             teeth (extensive caries, traumatic fractures, fractures of endodontically treated&#xD;
             teeth, root perforation, root resorption with or without radiographic periapical&#xD;
             lesion up to 3 mm in diameter). patients who are systemically healthy or with&#xD;
             controlled common systemic conditions (controlled hypertension, controlled diabetes&#xD;
             HbA1c up to 7 %).&#xD;
&#xD;
          -  adjacent teeth have to be present and the eligible tooth has esthetically acceptable&#xD;
             buccal gingival margin position prior to surgery, compared to neighboring teeth and&#xD;
             contralateral tooth, and adequate width of buccal keratinized gingiva(≥3mm).&#xD;
&#xD;
          -  level of radiographic bone level has the distance from CEJ to interproximal crest up&#xD;
             to 4 mm.&#xD;
&#xD;
          -  Location of buccal alveolar crest has to be generally within 4 mm from the free&#xD;
             gingival margin, verified after the extraction, before randomization; and&#xD;
             fenestration, if present, up to 3mm in diameter at the apical part of the root and&#xD;
             affecting less than 30% of the buccal socket wall.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  currently smoke exceeding 10 cigarettes/ day&#xD;
&#xD;
          -  severe parafunctional habits, malocclusion or intent of orthodontic therapy in the&#xD;
             future and are pregnant.&#xD;
&#xD;
          -  teeth in the surgical site will be excluded if there is advanced periodontal disease&#xD;
             or periapical lesion causing significant bony defects that are beyond the criteria&#xD;
             mentioned at Section 3.3.&#xD;
&#xD;
          -  allergy to antibiotics contained in the ADM (Gentimicin, Cefoxitin, Lincomcin,&#xD;
             polymixin B and Vancomycin) will not be included in the immediate implant combined&#xD;
             with ADM group.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun-Teh Lee, DDS, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Texas Health Science Center at Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 9, 2016</study_first_submitted>
  <study_first_submitted_qc>August 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2016</study_first_posted>
  <last_update_submitted>October 2, 2021</last_update_submitted>
  <last_update_submitted_qc>October 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Chun-Teh Lee</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

